SAPVAX
SapVax is advancing discoveries made by researchers from the University of Auckland in New Zealand. Their academic founders have developed a novel chemistry platform for coupling immunogenic peptides to TLR2-agonist adjuvants to generate fully-synthetic, self-adjuvanting cancer vaccines. The Sapvax team is developing a pipeline of products for the treatment of different cancers, with an initial focus on tumors expressing NY-ESO-1.
SAPVAX
Industry:
Biotechnology Health Care
Founded:
2016-01-01
Address:
Cleveland, Ohio, United States
Country:
United States
Website Url:
http://www.sapvaxllc.com
Total Employee:
1+
Status:
Active
Contact:
216-455-3200
Total Funding:
3.24 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Google Tag Manager Content Delivery Network Global Site Tag
Similar Organizations
Adastra Pharmaceuticals
Adastra Pharmaceuticals provides responsible solutions to advance patient care in oncology.
Elstar Therapeutics
Fulfilling the promise of precision cancer immunotherapy through a powerful new approach to generating multi-functional therapeutics.
Excision BioTherapeutics
Excision is developing CRISPR-based therapies to cure viral infectious diseases and improve the lives of chronically ill patients.
Impact Biomedicines
Impact Biomedicines is pioneering the development of life-changing treatments for patients.
Current Advisors List
Current Employees Featured
Founder
Official Site Inspections
http://www.sapvaxllc.com
- Host name: 69.28.91.108
- IP address: 69.28.91.108
- Location: Dallas United States
- Latitude: 32.7889
- Longitude: -96.8021
- Metro Code: 623
- Timezone: America/Chicago
- Postal: 75201
